These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25520636)

  • 1. Changes in cerebral metabolism in patients with a minimally conscious state responding to zolpidem.
    Chatelle C; Thibaut A; Gosseries O; Bruno MA; Demertzi A; Bernard C; Hustinx R; Tshibanda L; Bahri MA; Laureys S
    Front Hum Neurosci; 2014; 8():917. PubMed ID: 25520636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measures of metabolism and complexity in the brain of patients with disorders of consciousness.
    Bodart O; Gosseries O; Wannez S; Thibaut A; Annen J; Boly M; Rosanova M; Casali AG; Casarotto S; Tononi G; Massimini M; Laureys S
    Neuroimage Clin; 2017; 14():354-362. PubMed ID: 28239544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the evidence of zolpidem efficacy in neurological disability after brain damage due to stroke, trauma and hypoxia: A justification of further clinical trials.
    Sutton JA; Clauss RP
    Brain Inj; 2017; 31(8):1019-1027. PubMed ID: 28534652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcranial direct current stimulation effects in disorders of consciousness.
    Angelakis E; Liouta E; Andreadis N; Korfias S; Ktonas P; Stranjalis G; Sakas DE
    Arch Phys Med Rehabil; 2014 Feb; 95(2):283-9. PubMed ID: 24035769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Response to tDCS Depends on Residual Brain Metabolism and Grey Matter Integrity in Patients With Minimally Conscious State.
    Thibaut A; Di Perri C; Chatelle C; Bruno MA; Bahri MA; Wannez S; Piarulli A; Bernard C; Martial C; Heine L; Hustinx R; Laureys S
    Brain Stimul; 2015; 8(6):1116-23. PubMed ID: 26471400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of clinically significant responses to zolpidem among patients with disorders of consciousness: a preliminary placebo controlled trial.
    Whyte J; Myers R
    Am J Phys Med Rehabil; 2009 May; 88(5):410-8. PubMed ID: 19620954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of zolpidem in chronic disorders of consciousness: a prospective open-label study.
    Thonnard M; Gosseries O; Demertzi A; Lugo Z; Vanhaudenhuyse A; Bruno MA; Chatelle C; Thibaut A; Charland-Verville V; Habbal D; Schnakers C; Laureys S
    Funct Neurol; 2013; 28(4):259-64. PubMed ID: 24598393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Speech recovery after single-dose zolpidem in two minimally conscious patients with severe traumatic brain injuries: a case report.
    Zhou Y; Altonji KA; Kakkanatt A; Greenwald BD
    Brain Inj; 2024 Apr; 38(5):337-340. PubMed ID: 38308526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodal neurometabolic investigation of the effects of zolpidem on leukoencephalopathy-related apathy.
    Delorme C; Adanyeguh I; Bendetowicz D; Le Ber I; Ponchel A; Kas A; Habert MO; Mochel F
    Eur J Neurol; 2020 Nov; 27(11):2297-2302. PubMed ID: 32757342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating Disorders of Consciousness With Apomorphine: Protocol for a Double-Blind Randomized Controlled Trial Using Multimodal Assessments.
    Sanz LRD; Lejeune N; Blandiaux S; Bonin E; Thibaut A; Stender J; Farber NM; Zafonte RD; Schiff ND; Laureys S; Gosseries O
    Front Neurol; 2019; 10():248. PubMed ID: 30941094
    [No Abstract]   [Full Text] [Related]  

  • 11. Neural correlates of consciousness in patients who have emerged from a minimally conscious state: a cross-sectional multimodal imaging study.
    Di Perri C; Bahri MA; Amico E; Thibaut A; Heine L; Antonopoulos G; Charland-Verville V; Wannez S; Gomez F; Hustinx R; Tshibanda L; Demertzi A; Soddu A; Laureys S
    Lancet Neurol; 2016 Jul; 15(8):830-842. PubMed ID: 27131917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolpidem-Induced Arousal by Paradoxical GABAergic Stimulation: A Case Report With F-18 Flumazenil Positron Emission Tomography and Single Photon Emission Computed Tomography Study.
    Kim C; Kwon BS; Nam KY; Park JW; Lee HJ
    Ann Rehabil Med; 2016 Feb; 40(1):177-81. PubMed ID: 26949686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy.
    Brefel-Courbon C; Payoux P; Ory F; Sommet A; Slaoui T; Raboyeau G; Lemesle B; Puel M; Montastruc JL; Demonet JF; Cardebat D
    Ann Neurol; 2007 Jul; 62(1):102-5. PubMed ID: 17357126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional neuroanatomy of human sleep states after zolpidem and placebo: a H215O-PET study.
    Finelli LA; Landolt HP; Buck A; Roth C; Berthold T; Borbély AA; Achermann P
    J Sleep Res; 2000 Jun; 9(2):161-73. PubMed ID: 10849243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional neuroanatomy underlying the clinical subcategorization of minimally conscious state patients.
    Bruno MA; Majerus S; Boly M; Vanhaudenhuyse A; Schnakers C; Gosseries O; Boveroux P; Kirsch M; Demertzi A; Bernard C; Hustinx R; Moonen G; Laureys S
    J Neurol; 2012 Jun; 259(6):1087-98. PubMed ID: 22081100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic precision of PET imaging and functional MRI in disorders of consciousness: a clinical validation study.
    Stender J; Gosseries O; Bruno MA; Charland-Verville V; Vanhaudenhuyse A; Demertzi A; Chatelle C; Thonnard M; Thibaut A; Heine L; Soddu A; Boly M; Schnakers C; Gjedde A; Laureys S
    Lancet; 2014 Aug; 384(9942):514-22. PubMed ID: 24746174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of zolpidem on local cerebral glucose metabolism during non-REM sleep in normal volunteers: a positron emission tomography study.
    Gillin JC; Buchsbaum MS; Valladares-Neto DC; Hong CC; Hazlett E; Langer SZ; Wu J
    Neuropsychopharmacology; 1996 Sep; 15(3):302-13. PubMed ID: 8873114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The integrity of thalamo-dorsolateral prefrontal cortex tract: a key factor in residual consciousness in disorders of consciousness patients.
    Jung JY; Yoo YJ; Yoon MJ; Hong BY; Kim TW; Park GY; Lee JI; Lee SH; Im S; Lim SH
    Front Neurol; 2024; 15():1373750. PubMed ID: 39206298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential benefits of zolpidem in disorders of consciousness.
    Noormandi A; Shahrokhi M; Khalili H
    Expert Rev Clin Pharmacol; 2017 Sep; 10(9):983-992. PubMed ID: 28649875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral electrometabolic coupling in disordered and normal states of consciousness.
    Annen J; Frasso G; van der Lande GJM; Bonin EAC; Vitello MM; Panda R; Sala A; Cavaliere C; Raimondo F; Bahri MA; Schiff ND; Gosseries O; Thibaut A; Laureys S
    Cell Rep; 2023 Aug; 42(8):112854. PubMed ID: 37498745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.